Rakhi Naik MD, MHS
Associate Director for Hematology, Hematology/Oncology Fellowship Program; Associate Professor of Medicine, Hematology, Johns Hopkins Medicine, Baltimore, MarylandDr. Naik graduated from Duke University with a degree in Biomedical and Electrical Engineering and received her MD from Cornell Medical School. She also holds a Masters in Health Sciences (MHS) from the Johns Hopkins Bloomberg School of Public Health. Dr. Naik has been at Hopkins since 2006, serving as Osler residency housestaff, hematology fellow, and Assistant Chief of Service (Chief Resident) prior to being recruited to faculty as an Assistant Professor in May 2013. She currently serves as the Associate Director for Hematology for the Hematology-Oncology Fellowship Program and is an Associate Professor of Medicine at Johns Hopkins Medicine.
Dr. Naik’s primary research involves the genetic epidemiology of sickle hemoglobin disorders, with the goal of informing genetic counseling, screening and treatment guidelines. She is currently involved in several large-scale epidemiologic efforts using National Heart, Lung, and Blood Institute (NHLBI) population study cohorts to define clinical complications of sickle cell trait, including venous thromboembolism, renal disease, cardiovascular disease, and stroke.
Dr. Naik serves on the American Society of Hematology (ASH) Committee on Training and is a member of the ASH Recruitment and Retention Working Group, which aims to increase the recruitment of trainees into benign hematology.
Recent Contributions to PracticeUpdate:
- 2018 Top Stories in Benign Hematology: DOACs in Cancer
- Management of Iron Overload in Thalassemia Major
- Presence of Intracardiac or Intrapulmonary Shunts in Adults With Sickle Cell Anemia
- The Effect of Iron Chelation on Overall Survival in Sickle Cell Disease and β-Thalassemia
- Venous Thromboembolism in Children With Sickle Cell Disease: A Retrospective Cohort Study
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism